OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner, Álvaro de Mingo Pulido, Brian Ruffell
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 395

Showing 1-25 of 395 citing articles:

Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 359

Hydrogen sulfide: An endogenous regulator of the immune system
Nahzli Dilek, Andreas Papapetropoulos, Tracy Toliver‐Kinsky, et al.
Pharmacological Research (2020) Vol. 161, pp. 105119-105119
Open Access | Times Cited: 223

RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 197

The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake
Álvaro de Mingo Pulido, Kay Hänggi, Daiana P. Celias, et al.
Immunity (2021) Vol. 54, Iss. 6, pp. 1154-1167.e7
Open Access | Times Cited: 170

Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
Alicia Cristina Peña-Romero, Esteban Orenes‐Piñero
Cancers (2022) Vol. 14, Iss. 7, pp. 1681-1681
Open Access | Times Cited: 149

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Qian Hu, Qihui Bian, Dingchao Rong, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 141

Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy
Hao Tian, Guohao Wang, Wei Sang, et al.
Nano Today (2022) Vol. 43, pp. 101405-101405
Closed Access | Times Cited: 131

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 131

CXCR2 inhibition enables NASH-HCC immunotherapy
Jack Leslie, John B. G. Mackey, Thomas Jamieson, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2093-2106
Open Access | Times Cited: 123

The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases
Jin Liu, Zeyang Liu, Yan Pang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 105

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 93

Exosome-Mediated Immunosuppression in Tumor Microenvironments
Qihui Xie, Jiqi Zheng, Jiayi Ding, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1946-1946
Open Access | Times Cited: 87

Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84

Advancement of cancer immunotherapy using nanoparticles-based nanomedicine
Vemana Gowd, Anas Ahmad, Mohammad Tarique, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 624-644
Closed Access | Times Cited: 83

Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions
Peilin Lu, Dongxue Ruan, Meiqi Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 83

Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
Samuel Chuah, Joycelyn Jie Xin Lee, Yuan Song, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 683-694
Open Access | Times Cited: 71

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Lei Su, Yunhuan Gao, Rongcun Yang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50

Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 50

Migrasomes, a new mode of intercellular communication
Yuyun Jiang, Xi Liu, Jixian Ye, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 48

Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 44

Biomaterials for in situ cell therapy
Chang Wang, Siyu Wang, Diana D. Kang, et al.
BMEMat (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 43

Hydrogels as a Potential Biomaterial for Multimodal Therapeutic Applications
Harpreet Kaur, B.K. Gogoi, Ira Sharma, et al.
Molecular Pharmaceutics (2024)
Open Access | Times Cited: 19

Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention
Hong Huang, Gejing Li, Yini He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17

The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
Dongming Li, Donghui Cao, Yuanlin Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16

Page 1 - Next Page

Scroll to top